Fusaro Gina, Wang Sheng, Chellappan Srikumar
Department of Pathology, College of Physicians and Surgeons, Columbia University, 630 W 168th St, New York, NY 10032, USA.
Oncogene. 2002 Jul 4;21(29):4539-48. doi: 10.1038/sj.onc.1205551.
Prohibitin, a potential tumor suppressor, is known to induce growth suppression and repress E2F-mediated transcription. These growth regulatory functions of prohibitin require a physical interaction with the Rb protein. We now find that prohibitin protects cells from apoptosis mediated by camptothecin, a topoisomerase I inhibitor. Camptothecin treatment of Ramos B cells leads to the degradation of Rb protein and phosphorylation of its family members, p107 and p130. This correlates with an increase in the levels of cyclin E as well as the kinase activity associated with it. Inactivation of Rb leads to the dissociation and release of free E2F. We find also that E2F activity is induced upon camptothecin treatment, but this increase is absent in prohibitin overexpressing cells. It thus appears that prohibitin may be inhibiting apoptosis by downregulating E2F activity when Rb family members are inactive.
禁止素作为一种潜在的肿瘤抑制因子,已知其可诱导生长抑制并抑制E2F介导的转录。禁止素的这些生长调节功能需要与Rb蛋白进行物理相互作用。我们现在发现,禁止素可保护细胞免受喜树碱(一种拓扑异构酶I抑制剂)介导的细胞凋亡。用喜树碱处理Ramos B细胞会导致Rb蛋白降解及其家族成员p107和p130磷酸化。这与细胞周期蛋白E水平的增加以及与之相关的激酶活性增加相关。Rb的失活导致游离E2F的解离和释放。我们还发现,喜树碱处理后E2F活性被诱导,但在过表达禁止素的细胞中这种增加不存在。因此,当Rb家族成员无活性时,禁止素似乎可能通过下调E2F活性来抑制细胞凋亡。